Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosis.
Recent studies indicated that migraine is associated with specific vascular risk profile. However, the functional and structural vascular abnormalities in migraine are rarely addressed. We evaluated the vascular risk factors, endothelial function, and carotid artery (CA)-intima-media thickness (IMT), segregators of preclinical atherosclerosis, in migraineurs. This preliminary study included 63 adults with headache (migraine with aura [n=14], migraine without aura [n=24], transformed migraine [n=6], and tension headache [n=19]) and 35 matched healthy subjects. The following vascular risks were assessed: body mass index (BMI), systolic blood pressure (SBP) and diastolic blood pressures (DBP), serum levels of C-reactive protein, fasting glucose, fasting insulin, total cholesterol, and triglycerides. Plasma endothelin (ET)-1, a vasoactive peptide produced by vascular smooth muscle cells and marker for endothelial injury and atherosclerosis, was measured. Endothelial-dependent vasoreactivity was assessed using brachial artery flow-mediated dilatation (FMD) in response to hyperemia. CA-IMT, structural marker of early atherosclerosis, was measured. Compared with control subjects, SBP, DBP, glucose, insulin, ET-1, and CA-IMT were elevated with migraine. FMD% was inversely correlated with SBP (P < .001), DBP (P < .01), glucose (P < .001), and insulin levels (P < .01). CA-IMT was correlated with BMI (P < .05), SBP (P < .01), total cholesterol (P < .01), triglycerides (P < .001), glucose (P < .001), insulin (P < .01), and FMD% (P < .05). In multivariate analysis, ET-1 was correlated with duration of illness, SBP, DBP, glucose, insulin, IMT, and FMD%. We conclude that endothelial injury, impaired endothelial vasoreactivity, and increased CA-IMT occur with migraine and are associated with vascular risk factors that strongly suggest that migraine could be a risk for atherosclerosis.
Hamed
Sherifa A
SA
Department of Neurology, Assiut University Hospital, Egypt. hamed_sherifa@yahoo.com
Hamed
Enas A
EA
Ezz Eldin
Azza M
AM
Mahmoud
Nagia M
NM
D000328:Adult; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000502:physiology; D015992:Body Mass Index; D002097:C-Reactive Protein / Q000032:analysis / Q000378:metabolism; D002339:Carotid Arteries / Q000473:pathology / Q000503:physiopathology; D002340:Carotid Artery Diseases / Q000175:diagnosis / Q000453:epidemiology* / Q000503:physiopathology*; D016022:Case-Control Studies; D002784:Cholesterol / Q000032:analysis / Q000097:blood; D015897:Comorbidity; D048909:Diabetes Complications / Q000453:epidemiology / Q000503:physiopathology; D042783:Endothelial Cells / Q000378:metabolism; D019332:Endothelin-1 / Q000032:analysis / Q000097:blood; D005260:Female; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000503:physiopathology; D008297:Male; D008881:Migraine Disorders / Q000175:diagnosis / Q000453:epidemiology* / Q000503:physiopathology*; D015999:Multivariate Analysis; D012307:Risk Factors; D014280:Triglycerides / Q000032:analysis / Q000097:blood; D017539:Tunica Intima / Q000473:pathology / Q000503:physiopathology; D014661:Vasoconstriction / Q000502:physiology
D015415:Biomarkers; D001786:Blood Glucose; D019332:Endothelin-1; D014280:Triglycerides; D002097:C-Reactive Protein; D002784:Cholesterol